共 50 条
- [1] Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19 International Ophthalmology, 2023, 43 : 1919 - 1926
- [2] Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2022, 41 (03): : 275 - 286
- [5] Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2021, 37 (05): : 488 - 495
- [6] Transcutaneous retrobulbar amphotericin B for rhino-orbital-cerebral mucormycosis: a multi-center retrospective comparative study ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2024, 43 (01): : 41 - 48
- [8] Battling the emerging epidemic of rhino-orbital-cerebral mucormycosis (ROCM) in COVID-19 pandemic: an interventional study International Ophthalmology, 2023, 43 : 1571 - 1580
- [9] Post Covid-19 rhino-orbital-cerebral mucormycosis presenting as unilateral headache JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 2):